Is axillary lymph node clearance required in node-positive breast cancer?
Identifieur interne : 001226 ( PubMed/Curation ); précédent : 001225; suivant : 001227Is axillary lymph node clearance required in node-positive breast cancer?
Auteurs : Nigel J. Bundred [Royaume-Uni] ; Nicola L P. Barnes [Royaume-Uni] ; Emiel Rutgers [Pays-Bas] ; Mila Donker [Pays-Bas]Source :
- Nature reviews. Clinical oncology [ 1759-4782 ] ; 2015.
Descripteurs français
- KwdFr :
- Aisselle (), Aisselle (anatomopathologie), Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Micrométastase tumorale (anatomopathologie), Métastase lymphatique (anatomopathologie), Métastase lymphatique (diagnostic), Métastase lymphatique (radiothérapie), Noeuds lymphatiques (), Noeuds lymphatiques (anatomopathologie), Récidive tumorale locale (), Récidive tumorale locale (anatomopathologie), Récidive tumorale locale (radiothérapie), Résultat thérapeutique, Tumeurs du sein (anatomopathologie).
- MESH :
- anatomopathologie : Aisselle, Micrométastase tumorale, Métastase lymphatique, Noeuds lymphatiques, Récidive tumorale locale, Tumeurs du sein.
- diagnostic : Métastase lymphatique.
- radiothérapie : Métastase lymphatique, Récidive tumorale locale.
- Aisselle, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Noeuds lymphatiques, Récidive tumorale locale, Résultat thérapeutique.
English descriptors
- KwdEn :
- Axilla (pathology), Axilla (surgery), Breast Neoplasms (pathology), Female, Humans, Lymph Node Excision, Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphatic Metastasis (diagnosis), Lymphatic Metastasis (pathology), Lymphatic Metastasis (radiotherapy), Neoplasm Micrometastasis (pathology), Neoplasm Recurrence, Local (pathology), Neoplasm Recurrence, Local (radiotherapy), Neoplasm Recurrence, Local (surgery), Sentinel Lymph Node Biopsy, Treatment Outcome.
- MESH :
- diagnosis : Lymphatic Metastasis.
- pathology : Axilla, Breast Neoplasms, Lymph Nodes, Lymphatic Metastasis, Neoplasm Micrometastasis, Neoplasm Recurrence, Local.
- radiotherapy : Lymphatic Metastasis, Neoplasm Recurrence, Local.
- surgery : Axilla, Lymph Nodes, Neoplasm Recurrence, Local.
- Female, Humans, Lymph Node Excision, Sentinel Lymph Node Biopsy, Treatment Outcome.
Abstract
Although the majority of patients with breast cancer have clinically negative axillary nodes at preoperative assessment, around 15-20% of these women will have metastatic disease within the lymph nodes at operative sentinel node biopsy, and additional selective treatment to the axilla might be required. Local treatment to the axilla can include axillary node clearance or axillary radiotherapy. The recent results of the American College of Surgeons Oncology Group Z0011 trial suggested that some women would be safe from recurrence without further axillary treatment if they have less than three involved sentinel nodes, with no extracapsular spread. We review the evidence base for management of the axilla after detection of a positive sentinel node, discuss the evidence for why micrometastatic disease requires systemic but not axillary therapy, and present data suggesting that axillary irradiation for macrometastases gives equivalent control to axillary node clearance, but causes less morbidity such as lymphoedema. Ongoing trials will confirm whether any further therapy can be omitted for all patients with low volume, sentinel-node macrometastases.
DOI: 10.1038/nrclinonc.2014.188
PubMed: 25367714
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001226
Links to Exploration step
pubmed:25367714Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is axillary lymph node clearance required in node-positive breast cancer?</title><author><name sortKey="Bundred, Nigel J" sort="Bundred, Nigel J" uniqKey="Bundred N" first="Nigel J" last="Bundred">Nigel J. Bundred</name><affiliation wicri:level="1"><nlm:affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT</wicri:regionArea></affiliation></author><author><name sortKey="Barnes, Nicola L P" sort="Barnes, Nicola L P" uniqKey="Barnes N" first="Nicola L P" last="Barnes">Nicola L P. Barnes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT</wicri:regionArea></affiliation></author><author><name sortKey="Rutgers, Emiel" sort="Rutgers, Emiel" uniqKey="Rutgers E" first="Emiel" last="Rutgers">Emiel Rutgers</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Donker, Mila" sort="Donker, Mila" uniqKey="Donker M" first="Mila" last="Donker">Mila Donker</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25367714</idno><idno type="pmid">25367714</idno><idno type="doi">10.1038/nrclinonc.2014.188</idno><idno type="wicri:Area/PubMed/Corpus">001226</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001226</idno><idno type="wicri:Area/PubMed/Curation">001226</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001226</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Is axillary lymph node clearance required in node-positive breast cancer?</title><author><name sortKey="Bundred, Nigel J" sort="Bundred, Nigel J" uniqKey="Bundred N" first="Nigel J" last="Bundred">Nigel J. Bundred</name><affiliation wicri:level="1"><nlm:affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT</wicri:regionArea></affiliation></author><author><name sortKey="Barnes, Nicola L P" sort="Barnes, Nicola L P" uniqKey="Barnes N" first="Nicola L P" last="Barnes">Nicola L P. Barnes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT</wicri:regionArea></affiliation></author><author><name sortKey="Rutgers, Emiel" sort="Rutgers, Emiel" uniqKey="Rutgers E" first="Emiel" last="Rutgers">Emiel Rutgers</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam</wicri:regionArea></affiliation></author><author><name sortKey="Donker, Mila" sort="Donker, Mila" uniqKey="Donker M" first="Mila" last="Donker">Mila Donker</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam</wicri:regionArea></affiliation></author></analytic><series><title level="j">Nature reviews. Clinical oncology</title><idno type="eISSN">1759-4782</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla (pathology)</term><term>Axilla (surgery)</term><term>Breast Neoplasms (pathology)</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymph Nodes (pathology)</term><term>Lymph Nodes (surgery)</term><term>Lymphatic Metastasis (diagnosis)</term><term>Lymphatic Metastasis (pathology)</term><term>Lymphatic Metastasis (radiotherapy)</term><term>Neoplasm Micrometastasis (pathology)</term><term>Neoplasm Recurrence, Local (pathology)</term><term>Neoplasm Recurrence, Local (radiotherapy)</term><term>Neoplasm Recurrence, Local (surgery)</term><term>Sentinel Lymph Node Biopsy</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aisselle ()</term><term>Aisselle (anatomopathologie)</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Micrométastase tumorale (anatomopathologie)</term><term>Métastase lymphatique (anatomopathologie)</term><term>Métastase lymphatique (diagnostic)</term><term>Métastase lymphatique (radiothérapie)</term><term>Noeuds lymphatiques ()</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Récidive tumorale locale ()</term><term>Récidive tumorale locale (anatomopathologie)</term><term>Récidive tumorale locale (radiothérapie)</term><term>Résultat thérapeutique</term><term>Tumeurs du sein (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aisselle</term><term>Micrométastase tumorale</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques</term><term>Récidive tumorale locale</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphatic Metastasis</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Métastase lymphatique</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms</term><term>Lymph Nodes</term><term>Lymphatic Metastasis</term><term>Neoplasm Micrometastasis</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Lymphatic Metastasis</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Métastase lymphatique</term><term>Récidive tumorale locale</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Axilla</term><term>Lymph Nodes</term><term>Neoplasm Recurrence, Local</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Sentinel Lymph Node Biopsy</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Aisselle</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Femelle</term><term>Humains</term><term>Lymphadénectomie</term><term>Noeuds lymphatiques</term><term>Récidive tumorale locale</term><term>Résultat thérapeutique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Although the majority of patients with breast cancer have clinically negative axillary nodes at preoperative assessment, around 15-20% of these women will have metastatic disease within the lymph nodes at operative sentinel node biopsy, and additional selective treatment to the axilla might be required. Local treatment to the axilla can include axillary node clearance or axillary radiotherapy. The recent results of the American College of Surgeons Oncology Group Z0011 trial suggested that some women would be safe from recurrence without further axillary treatment if they have less than three involved sentinel nodes, with no extracapsular spread. We review the evidence base for management of the axilla after detection of a positive sentinel node, discuss the evidence for why micrometastatic disease requires systemic but not axillary therapy, and present data suggesting that axillary irradiation for macrometastases gives equivalent control to axillary node clearance, but causes less morbidity such as lymphoedema. Ongoing trials will confirm whether any further therapy can be omitted for all patients with low volume, sentinel-node macrometastases.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25367714</PMID><DateCreated><Year>2014</Year><Month>12</Month><Day>23</Day></DateCreated><DateCompleted><Year>2015</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-4782</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature reviews. Clinical oncology</Title><ISOAbbreviation>Nat Rev Clin Oncol</ISOAbbreviation></Journal><ArticleTitle>Is axillary lymph node clearance required in node-positive breast cancer?</ArticleTitle><Pagination><MedlinePgn>55-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/nrclinonc.2014.188</ELocationID><Abstract><AbstractText>Although the majority of patients with breast cancer have clinically negative axillary nodes at preoperative assessment, around 15-20% of these women will have metastatic disease within the lymph nodes at operative sentinel node biopsy, and additional selective treatment to the axilla might be required. Local treatment to the axilla can include axillary node clearance or axillary radiotherapy. The recent results of the American College of Surgeons Oncology Group Z0011 trial suggested that some women would be safe from recurrence without further axillary treatment if they have less than three involved sentinel nodes, with no extracapsular spread. We review the evidence base for management of the axilla after detection of a positive sentinel node, discuss the evidence for why micrometastatic disease requires systemic but not axillary therapy, and present data suggesting that axillary irradiation for macrometastases gives equivalent control to axillary node clearance, but causes less morbidity such as lymphoedema. Ongoing trials will confirm whether any further therapy can be omitted for all patients with low volume, sentinel-node macrometastases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bundred</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Nicola L P</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Academic Surgery, University Hospital of South Manchester, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutgers</LastName><ForeName>Emiel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donker</LastName><ForeName>Mila</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiotherapy, Netherlands Cancer Institute, Plesmanlaan 121, 100CX, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Clin Oncol</MedlineTA><NlmUniqueID>101500077</NlmUniqueID><ISSNLinking>1759-4774</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2013 Oct 9;310(14):1455-61</RefSource><PMID Version="1">24101169</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Feb;132(1):197-203</RefSource><PMID Version="1">22113254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1992;28A(8-9):1415-8</RefSource><PMID Version="1">1515262</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Sep;99(2):203-8</RefSource><PMID Version="1">16541308</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):653-63</RefSource><PMID Version="1">19675329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2006 Feb;95(3):279-93</RefSource><PMID Version="1">16163445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Apr;14(4):297-305</RefSource><PMID Version="1">23491275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2007 Apr 15;13(8):2329-34</RefSource><PMID Version="1">17438091</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource><PMID Version="1">23540561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Surg. 2004 Oct;91(10):1245-52</RefSource><PMID Version="1">15376203</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2013 Sep;24(9):2206-23</RefSource><PMID Version="1">23917950</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Aug 22;347(8):567-75</RefSource><PMID Version="1">12192016</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 1996 Jul;14(7):1982-92</RefSource><PMID Version="1">8683228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2011 Sep 1;29(25):3366-73</RefSource><PMID Version="1">21768458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2004 Jan 1;22(1):97-101</RefSource><PMID Version="1">14701770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2006 May 3;98(9):599-609</RefSource><PMID Version="1">16670385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource><PMID Version="1">21304082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2003 Apr;29(3):213-5</RefSource><PMID Version="1">12657228</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Nov;118(2):385-94</RefSource><PMID Version="1">19562480</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2013 Jun;49(9):2093-100</RefSource><PMID Version="1">23522754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2003 Dec;10(10):1152-9</RefSource><PMID Version="1">14654470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Dec;20(13):4145-52</RefSource><PMID Version="1">23959051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2012 Sep;256(3):428-36</RefSource><PMID Version="1">22868365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Pathol. 2002 Jun;33(6):579-89</RefSource><PMID Version="1">12152156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Feb 10;28(5):731-7</RefSource><PMID Version="1">20038733</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2008 Dec;34(12):1277-84</RefSource><PMID Version="1">18406100</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Oct;11(10):927-33</RefSource><PMID Version="1">20863759</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Jul 27;306(4):385-93</RefSource><PMID Version="1">21791687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Oct 20;23 (30):7703-20</RefSource><PMID Version="1">16157938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2014 Sep;23(9):1049-56</RefSource><PMID Version="1">24615880</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Apr 1;28(10):1677-83</RefSource><PMID Version="1">20065188</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2014 May 1;32(13):1365-83</RefSource><PMID Version="1">24663048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jun;133(3):831-41</RefSource><PMID Version="1">22147079</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2005 May 14-20;365(9472):1687-717</RefSource><PMID Version="1">15894097</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Aug 15;11(16):5678-85</RefSource><PMID Version="1">16115903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 Jun;14(7):609-18</RefSource><PMID Version="1">23683750</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2010 Sep;252(3):426-32; discussion 432-3</RefSource><PMID Version="1">20739842</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Jun 21;383(9935):2127-35</RefSource><PMID Version="1">24656685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 1996 Nov 6;88(21):1529-42</RefSource><PMID Version="1">8901851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 1999 Jan-Feb;6(1):109-16</RefSource><PMID Version="1">10030423</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061206" MajorTopicYN="N">Neoplasm Micrometastasis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="Y">Sentinel Lymph Node Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25367714</ArticleId><ArticleId IdType="pii">nrclinonc.2014.188</ArticleId><ArticleId IdType="doi">10.1038/nrclinonc.2014.188</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001226 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001226 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25367714
|texte= Is axillary lymph node clearance required in node-positive breast cancer?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25367714" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |